Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


New guidelines conclude all aerosol therapy devices equally effective


Patient education on aerosol therapy key to effective asthma control

New evidence-based guidelines for the selection of aerosol medication devices conclude that health-care providers should avoid basing device selection exclusively on device efficacy. Instead, the choice should be based on other patient-related factors. All aerosolized medication delivery systems are equally effective when used properly. Aerosolized medication is typically used to treat patients with respiratory conditions, such as asthma or chronic obstructive pulmonary disease (COPD).

For the first time, the American College of Chest Physicians (ACCP) and the American College of Allergy, Asthma, & Immunology (ACAAI) have developed joint evidence-based guidelines for the selection of aerosol delivery devices. Published in the January issue of CHEST, the peer-reviewed journal of the ACCP, the guidelines were developed by an international panel of pulmonary experts and provide recommendations on overall device selection and device selection for several commonly encountered clinical settings.

Based on a systematic review of pertinent randomized, controlled trials (RCT), panel members compared metered-dose inhalers (MDIs) with or without spacers/holding chambers, dry powder inhalers, and nebulizers, delivering both bronchodilators (beta2-agonists) and inhaled corticosteroids in order to determine the best recommendations for device selection. To achieve a fair comparison, RCTs were selected only if the same drug was used in the different delivery systems tested. Due to the limited number of published RCTs of inhaled corticosteroids, the majority of the studies reviewed and selected were RCTs of bronchodilators. Overall, guidelines state that aerosolized medication delivery systems, when used with comparable drug doses, provide equivalent efficacy and, therefore, recommend that health-care providers not base device selection exclusively on device efficacy but rather on several criteria, including device availability; cost; convenience; and the patient’s age, competence in using the device, and preference.

"The current practice of device selection for the delivery of aerosolized asthma or COPD medication is largely based on the device’s effectiveness in delivering the medication to the patient. Although there are advantages and disadvantages associated with each device and medication, when used properly, all aerosol devices can work equally well and can be interchanged," said guidelines chair Myrna B. Dolovich, P.Eng, Associate Clinical Professor Medicine & Radiology, McMaster University, Hamilton, Ontario, Canada. "Health-care providers should choose a device based on the individual characteristics of each patient. If asthma control is not achieved using one delivery device, it may be beneficial for patients to switch to another device after consulting with his or her provider."

Guidelines also incorporate recommendations for device selection in specific clinical settings, including the emergency department, ICU, and inpatient and outpatient situations. Specific recommendations include:

  • Inpatient setting: Nebulizers and MDIs with spacer/holding chambers are appropriate for use in the inpatient setting.
  • Emergency department setting: Nebulizers and MDIs with spacer/holding chambers are appropriate for delivery of beta2-agonists in the emergency department.
  • Patients supported by mechanical ventilation: Careful attention to details of the technique employed for administering medications by MDI or nebulizer to mechanically ventilated patients is critical, since multiple technical factors may have clinically important effects on the efficiency of aerosol delivery.

Panel members also strongly recommend that clinicians provide patients with sufficient instruction on the use of their aerosol inhaler in order to maximize asthma control. "Many health-care providers are confused by the large number of aerosol delivery devices available and have difficulty explaining their correct use to patients," said Professor Dolovich. "Physicians, respiratory therapists, and nurses caring for patients with respiratory diseases should be familiar with issues related to performance and correct use of aerosol delivery devices in order to instruct their patients on proper usage."

"Evidence-based guidelines are based on a comprehensive review of clinical research findings, allowing medical professionals to make the most effective and patient-focused decisions on the diagnosis and treatment of diseases," said Paul A. Kvale, MD, FCCP, President of the American College of Chest Physicians. "The new evidence-based guidelines for aerosol therapy integrate individual clinical expertise with the best available evidence on respiratory medication and delivery devices. Ultimately, by following these evidence-based guidelines, clinicians will have a more current and consistent approach to selecting aerosol therapy for patients."

"Use of inhaled aerosols has revolutionized the care of obstructive respiratory disease by allowing the selective delivery of optimal concentrations of drugs to the airway without creating the undesirable side effects that might result from systemic administration," said Myron J. Zitt, MD, President of the American College of Allergy, Asthma & Immunology. "Nonetheless, the caregiver is in a quandary as to which aerosol delivery system is best for his or her patient. The new evidence-based guidelines provide additional criteria for device selection. Regardless of what delivery system is chosen, patient education is essential to assure optimal outcomes."

Jennifer Stawarz | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>